AbCellera Biologics Other Current Assets

AbCellera Biologics (ABCL) currently reports a other current assets of $44M as of March 2026. That compares with $120M in the prior-year period — down 63.1% year over year. Use the charts on this page to explore AbCellera Biologics's other current assets history and peer comparisons.

AbCellera Biologics's other current assets decreased from $120M to $44M — a 63.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AbCellera Biologics reported $44M in other current assets as of March 2026. That compares with $120M in the prior-year period — down 63.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $44M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AbCellera Biologics, and consider following ABCL for alerts when major investors trade the stock.